Lidonexe
FDA Label NDC 69329-002

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Patchwerx Labs, Inc. for the product Lidonexe (NDC 69329-002). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding lidonexe patch, active ingredients:, purpose, uses:, warnings, keep out of reach of children., other, directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients:

Lidocaine HCL 4.00%

Menthol 1.00%


Directions

  • Clean and dry affected area.
  • Remove patch from backing and apply to affected area.
  • Use only one patch at a time, and maximum of four patches/day.
  • Leave patch on affected area for up to 8-hours.
  • Do not use patches for longer than five consecutive days.
  • Children under 12 should consult physician prior to use.

* Please review the disclaimer below.